Literature DB >> 16495578

Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine.

Shantini D Gamage1, Angela K Patton, Jane E Strasser, Claudia L Chalk, Alison A Weiss.   

Abstract

The presence of commensal flora reduced colonization of Escherichia coli O157:H7 and production of Shiga toxin (Stx) in the murine intestine. Stx production was not detected in mice colonized with E. coli that were resistant to the Shiga toxin phage, but it was detected in mice colonized with phage-susceptible E. coli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495578      PMCID: PMC1418637          DOI: 10.1128/IAI.74.3.1977-1983.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Bacteria-host communication: the language of hormones.

Authors:  Vanessa Sperandio; Alfredo G Torres; Bruce Jarvis; James P Nataro; James B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-07       Impact factor: 11.205

2.  Formation of ion channels by colicin B in planar lipid bilayers.

Authors:  J O Bullock; S K Armstrong; J L Shear; D P Lies; M A McIntosh
Journal:  J Membr Biol       Date:  1990-03       Impact factor: 1.843

3.  Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.

Authors:  E A Wadolkowski; J A Burris; A D O'Brien
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

4.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

5.  Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19.

Authors:  A Huang; S de Grandis; J Friesen; M Karmali; M Petric; R Congi; J L Brunton
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

6.  Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features.

Authors:  L Slutsker; A A Ries; K D Greene; J G Wells; L Hutwagner; P M Griffin
Journal:  Ann Intern Med       Date:  1997-04-01       Impact factor: 25.391

7.  Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine.

Authors:  Regina L Miranda; Tyrrell Conway; Mary P Leatham; Dong Eun Chang; Wendy E Norris; James H Allen; Sarah J Stevenson; David C Laux; Paul S Cohen
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.

Authors:  Motomichi Takahashi; Haruhiko Taguchi; Hiroyuki Yamaguchi; Takako Osaki; Akio Komatsu; Shigeru Kamiya
Journal:  FEMS Immunol Med Microbiol       Date:  2004-07-01

9.  Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs.

Authors:  H W Smith; P Green; Z Parsell
Journal:  J Gen Microbiol       Date:  1983-10

10.  Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2.

Authors:  Shantini D Gamage; Colleen M McGannon; Alison A Weiss
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

View more
  38 in total

1.  The SOS Response Mediates Sustained Colonization of the Mammalian Gut.

Authors:  Amanda N Samuels; Manuela Roggiani; Jun Zhu; Mark Goulian; Rahul M Kohli
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

2.  Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice.

Authors:  Kathryn A Eaton; Alexander Honkala; Thomas A Auchtung; Robert A Britton
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 3.  A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression.

Authors:  Erin M Nawrocki; Hillary M Mosso; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

4.  A Putative Microcin Amplifies Shiga Toxin 2a Production of Escherichia coli O157:H7.

Authors:  Hillary M Mosso; Lingzi Xiaoli; Kakolie Banerjee; Maria Hoffmann; Kuan Yao; Edward G Dudley
Journal:  J Bacteriol       Date:  2019-12-06       Impact factor: 3.490

Review 5.  Microbiome, inflammation, and cancer.

Authors:  Ralph Francescone; Vivianty Hou; Sergei I Grivennikov
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 6.  Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence.

Authors:  Dakshina M Jandhyala; Vijay Vanguri; Erik J Boll; Yushuan Lai; Beth A McCormick; John M Leong
Journal:  Infect Dis Clin North Am       Date:  2013-07-24       Impact factor: 5.982

Review 7.  Microbiota and pathogen 'pas de deux': setting up and breaking down barriers to intestinal infection.

Authors:  Elizabeth S McKenney; Melissa M Kendall
Journal:  Pathog Dis       Date:  2016-05-31       Impact factor: 3.166

8.  Accumulation of single-stranded DNA in Escherichia coli carrying the colicin plasmid pColE3-CA38.

Authors:  Magali Morales; Hedieh Attai; Kimberly Troy; David Bermudes
Journal:  Plasmid       Date:  2014-11-05       Impact factor: 3.466

9.  Different classes of antibiotics differentially influence shiga toxin production.

Authors:  Colleen Marie McGannon; Cynthia Ann Fuller; Alison Ann Weiss
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

10.  Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse Model.

Authors:  Kakolie Goswami; Chun Chen; Lingzi Xiaoli; Kathryn A Eaton; Edward G Dudley
Journal:  Infect Immun       Date:  2015-08-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.